June 13, 2016
Tag(s): Press Releases
June 13, 2016
4G Clinical Continues Swift Growth
Wellesley, MA (June 13, 2016) – 4G Clinical, a clinical trials technology leader that helps accelerate the development of new pharmaceuticals, announced today that it has signed a lease for office space in Wellesley, MA.
“As a vital partner to pharmaceutical companies in reducing their time to commercialize medications, our move to Wellesley will give us a strategic advantage,” said Dave Kelleher, Chief Executive Officer of 4G Clinical. “As we accelerate our growth and move toward marketing our products later this year, we want to be a key part of the biopharma cluster in Greater Boston that attracts some of the world’s leaders in the industry.”
4G Clinical delivers validated randomization and trial supply management capabilities to pharmaceutical companies and contract research organizations.
The office, located at 370 Washington Street in Wellesley, will serve as 4G Clinical’s new headquarters and provide office and research space for approximately 25 employees. The company also has employees throughout Europe working with pharmaceutical and contract research organizations in the EU market.
The office will be ready for occupancy in early September.
About 4G Clinical
4G Clinical powers the clinical trial research capabilities of pharmaceutical companies and Contract Research Organizations. 4G Clinical’s Randomization and Trial Supply Management (RTSM) technology provides a major advancement in customizing and processing trials that speed development of new drug therapies. The company’s Prancer platform is the next generation solution for pharmaceutical research and development.
Ed Tourtellotte, 4G Clinical CTO was the founder of Tourtellotte Solutions, a clinical trials consulting and technology company (acquired by Bioclinica). Ed designed and built the world’s first configurable IRT in 2000, and also designed the clinical trial supply simulator tcVisualize as well as Trident IWR.